Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Neuromuscular Research

University of Toronto

$167,406.00

The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis

FY 2010-11

Summary
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is an adult-onset neurodegenerative disease that affects motor neurons of the brain and spinal cord, causing paralysis and death within 2-5 years. There is no cure or effective treatment. A major protein associated with ALS is the TAR DNA Binding Protein (TDP-43). TDP-43 is a major component of the pathological inclusion bodies characteristic of ALS, and mutations in the TDP-43 gene are found in a subset of both familial and sporadic ALS patients. Our goal is to understand how TDP-43 could cause ALS as a means to developing strategies to treat the disease. To do this we use both studies in culture and transgenic mouse models of the disease.
Program
Operating Grant - Priority Announcement: Neuromuscular Research
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
230648
Name
Robertson Janice
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Amyotrophic Lateral Sclerosis Society of Canada
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$167,406
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Neuromuscular Research
Keyworddelim
Amyotrophic Lateral Sclerosis; Neuropathology; Protein Biochemistry; Tar-Dna-Binding Protein; Transgenic Mice; Ubiquitinated Inclusions
Abstract
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is an adult-onset neurodegenerative disease that affects motor neurons of the brain and spinal cord, causing paralysis and death within 2-5 years. There is no cure or effective treatment. A major protein associated with ALS is the TAR DNA Binding Protein (TDP-43). TDP-43 is a major component of the pathological inclusion bodies characteristic of ALS, and mutations in the TDP-43 gene are found in a subset of both familial and sporadic ALS patients. Our goal is to understand how TDP-43 could cause ALS as a means to developing strategies to treat the disease. To do this we use both studies in culture and transgenic mouse models of the disease.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Robertson, Janice
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $55,828~ $0~Inst of Neurosc Mental Hlth &A~ $55,828~ $0~Institute of Genetics~ $55,750~ $0~